These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11494747)
1. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases]. Miheller P; Tóth M; Molnár E; Zágoni T; Rácz K; Tulassay Z Orv Hetil; 2001 Jul; 142(29):1557-60. PubMed ID: 11494747 [TBL] [Abstract][Full Text] [Related]
2. Altered bone metabolism in inflammatory bowel disease. Bischoff SC; Herrmann A; Göke M; Manns MP; von zur Mühlen A; Brabant G Am J Gastroenterol; 1997 Jul; 92(7):1157-63. PubMed ID: 9219790 [TBL] [Abstract][Full Text] [Related]
3. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nakajima S; Iijima H; Egawa S; Shinzaki S; Kondo J; Inoue T; Hayashi Y; Ying J; Mukai A; Akasaka T; Nishida T; Kanto T; Tsujii M; Hayashi N Nutrition; 2011 Oct; 27(10):1023-8. PubMed ID: 21482072 [TBL] [Abstract][Full Text] [Related]
4. [Improvement of bone metabolism after infliximab therapy in Crohn's disease]. Miheller P; Muzes G; Zágoni T; Tóth M; Rácz K; Tulassay Z Orv Hetil; 2005 Jul; 146(28):1477-80. PubMed ID: 16130441 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease. Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778 [TBL] [Abstract][Full Text] [Related]
7. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients]. Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305 [TBL] [Abstract][Full Text] [Related]
8. Body composition in patients with inflammatory bowel disease: a population-based study. Jahnsen J; Falch JA; Mowinckel P; Aadland E Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577 [TBL] [Abstract][Full Text] [Related]
9. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Herrlinger KR; Noftz MK; Dalhoff K; Ludwig D; Stange EF; Fellermann K Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276 [TBL] [Abstract][Full Text] [Related]
11. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831 [TBL] [Abstract][Full Text] [Related]
12. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331 [TBL] [Abstract][Full Text] [Related]
13. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
14. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [TBL] [Abstract][Full Text] [Related]
16. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095 [TBL] [Abstract][Full Text] [Related]
17. A study on bone mineral density in patients with Crohn's disease. Oshima T; Taira S; Nonaka M; Hayama Y; Yagi K; Yukawa I; Koh M; Kondo M; Kawakami K; Kawai T; Miyaoka M; Sakai Y; Moriyasu F; Matauoka H; Yamamoto K Hepatogastroenterology; 2008; 55(88):2116-20. PubMed ID: 19260488 [TBL] [Abstract][Full Text] [Related]
18. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132 [TBL] [Abstract][Full Text] [Related]
19. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398 [TBL] [Abstract][Full Text] [Related]
20. Biochemical markers and bone densitometry in inflammatory bowel disease. Ledro Cano D; Torres Domínguez Y; Castro Laria L; Sáenz Dana M; Herrerías Esteban JM; Herrerías Gutiérrez JM Rev Esp Enferm Dig; 2000 Sep; 92(9):595-600. PubMed ID: 11138241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]